Mitraclip
Payments companies reported to CMS as associated with Mitraclip. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mitraclip, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mitraclip
These are the largest totals companies reported as associated with Mitraclip. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Sorajja | Phoenix, AZ | Interventional Cardiology | $151,580.20 |
| Ganesh Keshav Thirunavukkarasu | Lexington, KY | Interventional Cardiology | $100,000.00 |
| Gagan Singh | Sacramento, CA | Cardiovascular Disease | $84,890.72 |
| Steven Bailey | Shreveport, LA | Interventional Cardiology | $82,375.00 |
| Edris Aman | Sacramento, CA | Cardiovascular Disease | $80,268.73 |
| Bassem Chehab | Wichita, KS | Cardiovascular Disease | $73,512.94 |
| Michael Morse | Nashville, TN | Interventional Cardiology | $73,268.60 |
| Isis Mahamid Abu Mouch | New York, NY | Interventional Cardiology | $68,182.00 |
| Andrea Soares | Sacramento, CA | Cardiovascular Disease | $67,500.00 |
| Frederick St Goar | Mountain View, CA | Interventional Cardiology | $67,265.84 |
Prescribed Mitraclip?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.